Skip to main content
Erschienen in: Trials 1/2013

Open Access 01.11.2013 | Oral presentation

Design considerations in the development of a core outcome set

verfasst von: Nicola Harman, Iain Bruce, Peter Callery, Stephanie Tierney, Kevin O'Brien, Paula Williamson

Erschienen in: Trials | Sonderheft 1/2013

No gold standard method currently exists for the development of a core outcome set (COS) although key issues to consider have been identified [1]. Methodological decisions in the design of a project to develop a COS for otitis media with effusion (OME) in children with cleft palate (CP) will be explained.

Stakeholder groups

Clinicians involved in the management of OME were identified as: ENT surgeons; audiologists; cleft surgeons; speech and language therapists; specialist nurses. Discussions with CLAPA patient groups resulted in a Delphi for patients (7-11, 12-16 years), their parents and adults with CP and OME.

Separate Delphi panels

A Delphi exercise has been undertaken with each clinical stakeholder group separately. This method does not assume that different stakeholder groups will have the same outcome priorities.

Describing outcomes for patients and their parents

A lay description written for each outcome was reviewed by CLAPA groups and reading age assessed. Understanding was tested in a subsample using the think aloud method.

Delivery of the Delphi online

Each round of the Delphi was delivered online using a bespoke system that managed participation invitations , reminders, data collection and reporting.

Integration of clinical and patient views

Results of the separate Delphi surveys for each stakeholder group will be shared with all participants with an opportunity to re-score. Clinicians, adults, patients and their parents who have taken part in a Delphi panel/qualitative interview will be invited to a consensus meeting, facilitated by a Study Advisory Group and CLAPA members, to discuss the final COS.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Literatur
1.
Zurück zum Zitat Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P: Developing core outcome sets for clinical trials: issues to consider. Trials. 2012, 13: 132-10.1186/1745-6215-13-132.PubMedCentralCrossRefPubMed Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P: Developing core outcome sets for clinical trials: issues to consider. Trials. 2012, 13: 132-10.1186/1745-6215-13-132.PubMedCentralCrossRefPubMed
Metadaten
Titel
Design considerations in the development of a core outcome set
verfasst von
Nicola Harman
Iain Bruce
Peter Callery
Stephanie Tierney
Kevin O'Brien
Paula Williamson
Publikationsdatum
01.11.2013
Verlag
BioMed Central
Erschienen in
Trials / Ausgabe Sonderheft 1/2013
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-14-S1-O68

Weitere Artikel der Sonderheft 1/2013

Trials 1/2013 Zur Ausgabe